General Information of the Compound
Compound ID
CP0256595
Compound Name
2-[4-[6-[(4-fluorophenyl)methyl]-2-pyridin-2-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl]-N,N-dimethylethanamine
    Show/Hide
Structure
Formula
C27H34FN7
Molecular Weight
475.616
Canonical SMILES
CN(C)CCN1CCN(CC1)c1nc(nc2CCN(Cc3ccc(F)cc3)Cc12)-c1ccccn1
    Show/Hide
InChI
InChI=1S/C27H34FN7/c1-32(2)13-14-33-15-17-35(18-16-33)27-23-20-34(19-21-6-8-22(28)9-7-21)12-10-24(23)30-26(31-27)25-5-3-4-11-29-25/h3-9,11H,10,12-20H2,1-2H3
    Show/Hide
InChIKey
ZGRHTSMDPNPJSN-UHFFFAOYSA-N
Physicochemical Property
logP
2.9196
Rotatable Bonds
7
Heavy Atom Count
35
Polar Areas
51.63
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
35

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127041881
ChEMBL ID
CHEMBL3747405
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS